Comparing the effect of intravenous XXXX , intravenous @entity3974 , and their combination on @entity1209 in cesarean section with spinal anesthesia.

@entity1 @entity3974 @entity390 @entity391 @entity619 @entity1209
BACKGROUND: @entity1209 are frequently seen in @entity1 undergoing cesarean section (CS) under regional anesthesia. We aimed to compare the antiemetic efficacy of @entity3974 and @entity619 combination with that of the use of each agent alone to decrease the incidence of postdelivery intra- and post-operative @entity1209 during CS under spinal anesthesia. MATERIALS AND METHODS: A randomized, prospective, double-blind study was performed on 90 @entity1 undergoing planned CS under spinal anesthesia. The @entity1 received 4 mg @entity3974 in Group O, 8 mg @entity619 in Group D, and 4 mg @entity3974 +8 mg @entity619 in Group OD intravenously within 1-2 min after the umbilical cord was clamped. Frequency of postdelivery intra- and post-operative @entity1209 episodes was recorded. RESULTS: A total of 90 eligible @entity1 were included in the study. There were 30 @entity1 in Group O, 30 @entity1 in Group D, and 30 @entity1 in Group OD. Intraoperative @entity390 in Group D was more than the other two groups. @entity1209 in group OD was lesser than the other two groups. Intraoperative @entity391 in Group OD was lesser than the other two groups. There was no statistically significant difference among the @entity1209 (P > 0.05). CONCLUSION: Combined use of @entity619 and @entity3974 for the same indication seems to increase the antiemetic efficacy.
